Posted by admin on May 4th, 2022
Castings (LON:CGS – Get Rating) ‘s stock had its “buy” rating restated by analysts at Canaccord Genuity Group in a research report issued on Wednesday, Marketbeat.com reports. They currently have a GBX 530 ($6.62) target price on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 65.63% from the company’s previous close.
Shares of CGS stock opened at GBX 320 ($4.00) on Wednesday. The business has a fifty day moving average of GBX 314.79. Castings has a 52 week low of GBX 282.52 ($3.53) and a 52 week high of GBX 420 ($5.25). The stock has a market cap of £139.47 million and a PE ratio of 15.46.
In other Castings news, insider Brian J. Cooke bought 3,500 shares of the firm’s stock in a transaction dated Thursday, March 10th. The shares were purchased at an average cost of GBX 312 ($3.90) per share, for a total transaction of £10,920 ($13,641.47). Also, insider Brian J. Cooke purchased 5,000 shares of the stock in a transaction that occurred on Wednesday, April 6th. The stock was acquired at an average cost of GBX 304 ($3.80) per share, with a total value of £15,200 ($18,988.13). Insiders have acquired a total of 10,500 shares of company stock valued at $3,206,000 in the last 90 days.
Castings P.L.C. engages in the iron casting and machining activities. It operates through Foundry Operations and Machining Operations segments. The company offers ductile iron, spheroidal graphite iron, austempered ductile iron, SiMo, grey iron, and Ni-resist castings. It also provides fertilising solution annealing, pearlitic quench and temper, temper softening, and austempering heat treatment services; automotive standard e-coat and powder coating, galvanising, plating, gas based surface treatment, and plastic and metal spray coating services; and assembly and insulation services.
Receive News & Ratings for Castings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castings and related companies with MarketBeat.com's FREE daily email newsletter.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) COO Brendan Teehan Sells 552 Shares
Global Ship Lease (NYSE:GSL) Downgraded to “C+” at TheStreet